Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
04/04/2025 09:58 AM - Society
Mother of abandoned dead newborn referred for prosecution
04/03/2025 10:03 PM - Politics
Lai pledges 'maximum support' for Taiwan businesses amid U.S. 32% tariff
04/03/2025 09:55 PM - Business
Taiwan needs to address trade barriers after U.S. tariffs: Economists
04/03/2025 09:51 PM - Society
First-ever beaching of complete fin whale in Taiwan confirmed
04/03/2025 08:53 PM